ClinicalTrials.Veeva

Menu

Exercise Intolerance in Post-COVID Patients (EXILE)

Karolinska Institute logo

Karolinska Institute

Status

Active, not recruiting

Conditions

Post-COVID Syndrome

Treatments

Procedure: High-Intensity-Interval-Exercise
Procedure: Moderate-Intensity-Continuous-Exercise
Procedure: Strength training
Procedure: Baseline assessment
Procedure: 1 year follow-up

Study type

Interventional

Funder types

Other

Identifiers

NCT05445830
2021-05758-01

Details and patient eligibility

About

The post-COVID syndrome poses an unprecedented challenge to modern society, affecting millions of people worldwide. Persistent fatigue and exercise intolerance are among the most common complaints of these subjects. The mechanisms of exercise intolerance in post-COVID subjects are remained yet unknown, which make the rehabilitation efforts complex and challenging. The overall goals of this project are to: 1) improve physiological understanding of symptoms in this clinical condition, 2) elucidate plausible mechanisms to explain exercise intolerance/symptom exacerbation, and finally 3) provide knowledge that can be directly applied in the clinical setting to improve diagnosis, care, and individualized rehabilitation of subjects with post-COVID syndrome. Post-COVID subjects and age/sex matched healthy controls will undertake a comprehensive set of physiological and functional assessments, followed by 3 experimental visits (in a randomized order), where acute exercise responses will be assessed in either continuous moderate intensity aerobic exercise, high intensity interval exercise, or strength training. The same set of physiological assessments will also be performed after 1 year in both post-COVID subjects and healthy-matched controls to better understand the time course of the syndrome. It is hypothesized that the mechanism responsible for exercise intolerance is linked to specific symptoms and will vary across subjects. However, it is expected that most post-COVID subjects will respond well to at least one type of exercise.

Enrollment

62 patients

Sex

All

Ages

18 to 64 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Verified test of covid-19 infection (PCR, or antigen or antibody before vaccination) (mandatory only for post-COVID group)
  • Symptoms persisting for at least 3 months (validaded with DSQ-PEM questionnarie) (only for post-COVID group)

Exclusion criteria

  • Subject's complaints may have been present before March 2020
  • Previous history cardiovascular, respiratory disease or other autoimmune disease
  • History of general anxiety syndrome or somatic symptom disorder

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

62 participants in 2 patient groups

Post-covid patients
Experimental group
Treatment:
Procedure: 1 year follow-up
Procedure: Baseline assessment
Procedure: Strength training
Procedure: Moderate-Intensity-Continuous-Exercise
Procedure: High-Intensity-Interval-Exercise
Control
Experimental group
Treatment:
Procedure: 1 year follow-up
Procedure: Baseline assessment
Procedure: Strength training
Procedure: Moderate-Intensity-Continuous-Exercise
Procedure: High-Intensity-Interval-Exercise

Trial contacts and locations

1

Loading...

Central trial contact

Andrea Tryfonos, PhD; Tommy Lundberg, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems